Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Initial Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02148380
What this trial is testing

Combination of Chemotherapy and Gefitinib as First-line Treatment

Who this might be right for
Non-Small-Cell Lung Cancer
Baohui Han 121
Large-scale testing (Phase 3)Study completedNCT00193596
What this trial is testing

Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site

Who this might be right for
Neoplasms, Unknown Primary
SCRI Development Innovations, LLC 198
Testing effectiveness (Phase 2)Study completedNCT00428142
What this trial is testing

Bortezomib, Combination Chemotherapy, and Rituximab as First-Line Therapy in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
NCIC Clinical Trials Group 95
Not applicableLooking for participantsNCT05751473
What this trial is testing

Reducing Posttraumatic Stress Disorder (PTSD) Symptoms in First Responders and Frontline Health Care Workers

Who this might be right for
Post Traumatic Stress Disorder
University of Michigan 410
Large-scale testing (Phase 3)WithdrawnNCT01355783
What this trial is testing

Trial of E7777 in Combination With CHOP Compared With CHOP Alone for the First-Line Treatment of Peripheral T-cell Lymphoma

Who this might be right for
Peripheral T-Cell Lymphoma
Eisai Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT06584227
What this trial is testing

Adebrelimab and Chidamide for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer, Adult
Liu Xiufeng 45
Testing effectiveness (Phase 2)Study completedNCT00344773
What this trial is testing

First-line Treatment for Adenocarcinoma Patients With Epidermal Growth Factor Receptor (EGFR) Mutation

Who this might be right for
Pulmonary Cancer
AstraZeneca 46
Not applicableLooking for participantsNCT07285096
What this trial is testing

P-CABs-based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication

Who this might be right for
Helicobacter Pylori Infection
Yueyue Li 1,730
Early research (Phase 1)UnknownNCT05557903
What this trial is testing

Phase Ⅰ Clinical Study of Anti-CD52 Monoclonal Antibody in NHL and T-PLL

Who this might be right for
Lymphoma, Non-HodgkinLymphoma, T-Cell
Lanzhou Institute of Biological Products Co., Ltd 71
Not applicableStudy completedNCT03858959
What this trial is testing

A Topical Desiccant Agent in Association With Manual Debridement in the Treatment of Peri-implant Mucositis

Who this might be right for
Peri-implant Mucositis
Universita di Verona 23
Large-scale testing (Phase 3)Not Yet RecruitingNCT06616259
What this trial is testing

First-line Treatment of MCapOX + Cetuximab Vs. MFOLFOX6 + Cetuximab for RAS/BRAF Wild-type, MSS, Unresectable Left-Sided MCRC: a Multicenter, Randomized, Controlled, Phase III Study

Who this might be right for
Colorectal Cancer (CRC)CapecitabineCetuximab
Meng Qiu 452
Not applicableActive Not RecruitingNCT07215962
What this trial is testing

Long-Term Safety Outcomes and First-Line Treatment Patterns in Patients With Non-Small Cell Lung Cancer and Programmed Death-1 (Pd-L1) <1%

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Bristol-Myers Squibb 300
Post-approval studies (Phase 4)Study completedNCT00963573
What this trial is testing

Efficacy & Safety of Loratadine-Betamethasone Oral Solution for Treatment of Severe Perennial Allergic Rhinitis in Children (Study P03428)

Who this might be right for
Rhinitis
Merck Sharp & Dohme LLC 100
Testing effectiveness (Phase 2)Ended earlyNCT03138083
What this trial is testing

OMO-1 in Solid Malignancies

Who this might be right for
Neoplasms
Octimet Oncology N.V. 40
Testing effectiveness (Phase 2)Ended earlyNCT02626754
What this trial is testing

A Prospective Study on Sunitinib as First Line Therapy for Advanced/Metastatic Renal Cell Carcinoma in Asian Population

Who this might be right for
Renal Cell Carcinoma
vghtpe user 13
Testing effectiveness (Phase 2)Ended earlyNCT01009346
What this trial is testing

RAD001 in Combination With Cetuximab and Cisplatin in Recurrent and Metastatic SCCHN

Who this might be right for
Head and Neck Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 9
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07443488
What this trial is testing

Efficacy and Safety of Olverembatinib Plus Inotuzumab Ozogamicin as First-Line Consolidation Therapy Followed by HSCT in Ph+ ALL

Who this might be right for
HSCTPh+ ALL
Institute of Hematology & Blood Diseases Hospital, China 20
Testing effectiveness (Phase 2)Study completedNCT01630083
What this trial is testing

Efficacy and Safety of IMAB362 in Combination With the EOX Regimen for CLDN18.2-positive Gastric Cancer

Who this might be right for
CLDN18.2-positive Adenocarcinoma of the Gastroesophageal JunctionCLDN18.2-positive Adenocarcinoma of EsophagusCLDN18.2-positive Gastric Adenocarcinoma
Astellas Pharma Global Development, Inc. 252
Not applicableUnknownNCT02522923
What this trial is testing

Back-on-Track Studying Early Quality Care

Who this might be right for
Musculoskeletal Diseases
Temple University 150
Large-scale testing (Phase 3)Study completedNCT00472862
What this trial is testing

Neurocognitive Training Integrated in OPUS Treatment Versus OPUS Treatment-as-usual

Who this might be right for
Schizophrenia
Neurocom 117
Next Page